FAMOUS SAMS GROUP INC
10QSB/A, 1998-08-11
EATING PLACES
Previous: STORAGE TRUST REALTY, 10-Q, 1998-08-11
Next: SPORTS AUTHORITY INC /DE/, 8-K, 1998-08-11




                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                  FORM 10-QSB/A

(Mark One)

[X]     QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES 
EXCHANGE ACT OF 1934

For the quarterly period ended:                    March 31, 1998

OR

[  ]    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES 
EXCHANGE OF 1934

For the transition period from                     to

Commission file number:  0-24736

                   BioProgress Technology International, Inc.
                       (formerly Famous Sam's Group Inc.)

        (Exact name of small business issuer as specified in its charter)

                 Nevada
     (State or other jurisdiction of               88-0361701       
     incorporation or organization)             (I.R.S. employer    
                                             identification number) 
 9055 Huntcliff Trace, Atlanta, Georgia
(Address of Principal executive offices)           30350-1735
                                                   (Zip Code)

Registrant's telephone number, including area code:  (770) 641-0264

Indicate by check mark whether the issuer (1) has filed all reports  required to
be filed by Section 13 or 15(d) of the  Securities  Exchange  act of 1934 during
the  preceding 12 months (or for such  shorter  period that the  registrant  was
required  to file  such  reports),  and  (2) has  been  subject  to such  filing
requirements for the past 90 days. Yes  No  X

Indicate the number of shares  outstanding  of each of the  issuer's  classes of
common stock, as of the latest practicable date: As of July 31, 1998, there were
approximately 4,999,753 shares outstanding.


<PAGE>


                           PART II - OTHER INFORMATION

Item 6.  Exhibits and Reports on Form 8-K

Exhibit 27 - Financial Data Schedule


                                           - 2 -


<PAGE>


                                   SIGNATURES

Pursuant to the  requirements of Section 13 or 15(d) of the Securities  Exchange
Act of 1934,  the  registrant  has duly  caused  this report to be signed on its
behalf  by the  undersigned,  thereunto  duly  authorized  as of this 7th day of
August, 1998.

BIOPROGRESS TECHNOLOGY INTERNATIONAL, INC.
(Registrant)

By:  /s/ Barry J. Muncaster
     ----------------------
     Barry J. Muncaster, President
      and Chief Executive Officer

    /s/ James T.C. Longley
    ----------------------
    James T. C. Longley, Chief Financial
    Officer
    (Principal Financial Officer)



<TABLE> <S> <C>


<ARTICLE>                      5
<MULTIPLIER>                                   1

       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                              DEC-31-1998
<PERIOD-END>                                   MAR-31-1998
<CASH>                                            500
<SECURITIES>                                        0
<RECEIVABLES>                                  96,994
<ALLOWANCES>                                        0
<INVENTORY>                                         0
<CURRENT-ASSETS>                               97,494
<PP&E>                                          4,000
<DEPRECIATION>                                      0
<TOTAL-ASSETS>                                101,494
<CURRENT-LIABILITIES>                          13,670
<BONDS>                                             0
                               0
                                         0
<COMMON>                                         5000
<OTHER-SE>                                     87,823
<TOTAL-LIABILITY-AND-EQUITY>                  101,494
<SALES>                                             0
<TOTAL-REVENUES>                                    0
<CGS>                                               0
<TOTAL-COSTS>                                       0
<OTHER-EXPENSES>                              191,177
<LOSS-PROVISION>                                    0
<INTEREST-EXPENSE>                                  0
<INCOME-PRETAX>                              (191,177)
<INCOME-TAX>                                        0
<INCOME-CONTINUING>                                 0
<DISCONTINUED>                                      0
<EXTRAORDINARY>                                     0
<CHANGES>                                           0
<NET-INCOME>                                 (191,177)
<EPS-PRIMARY>                                      (0.01)
<EPS-DILUTED>                                      (0.01)
        


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission